Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
This overview explains risk parity investing and how allocating risk rather than capital can influence retirement portfolio stability.
26,917 articlesHims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
As Root releases its 2025 earnings, investors want answers beyond a single number. This guide breaks down the key dri...
Block reveals a plan to slash thousands of roles with AI tools, but critics warn the move may miss broader shifts in ...
The plant-based meat craze brought BYND into the spotlight, but the path forward is uncertain. This guide examines wh...
Investors are watching a potential defense-spending surge as the iran conflict could feed new arms orders, lifting de...
Polychain Capital has secured a $200 million first close for its fourth crypto fund, with plans to reach roughly $400...
Wealthy family offices are reassessing multi-generational real estate bets as the market shifts and the Great Wealth ...
MP Materials is turning a quiet corner in the US defense supply chain, with Pentagon-backed pricing and a plan to bui...
Alphabet stands at a crossroads: Sundar Pichai could pull in up to $692 million over three years, but half of that de...
In March 2026, XRP and Ethereum trade near multi-month lows. This piece analyzes how far a $1,000 bet could grow in e...
Adobe shares have a tough year, yet JPMorgan sees upside. A $420 year-end target hinges on improving ARR, rising RPO,...
Nebius inked a $27 billion AI infrastructure deal with Meta, locking in vast capacity and signaling its edge in the n...